This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.An emerging topic in current immunobiology is the vital role that glycolipid-enriched membrane rafts have in immune cell activation and functioning. Among these roles is that of antigen (Ag) presentation to T cells by antigen presenting cells (APCs). For example, a recently published study from my laboratory showed that B cell APC rafts are assembled at the site of Ag presentation, and assembly of the APC rafts was essential for efficient stimulation of the T cells. Characterization of the APC rafts also showed that: signals for raft assembly were initiated in part by MHC II, the signals were enriched in the rafts, and they resulted in actin polymerization and an actin-dependent capping of the rafts for Ag presentation. From these results, we have proposed a model where MHC II and accessory molecules that include CD48 initiate signals within membrane rafts, and this leads to actin polymerization and actin-dependent translocation of rafts to the site of Ag presentation. As MHC II is associated with the rafts, this may allow the rafts to function as a vehicle for targeting peptide bound MHC II complexes to the site of engagement with the TCR. To test our model, we will in this proposal selectively disrupt the raft-associated signaling that occurs downstream of MHC II by constitutively targeting the protein tyrosine phosphatase SHP-1 to rafts using the membrane-anchoring signal of p56lck.
Aim 1 will consist of constructing a cDNA sequence encoding the raft-targeted SHP-1 protein, as well as a second sequence encoding a SHP-1 molecule that is targeted to the non-raft fraction of cell membranes. The latter will therefore serve to control for specificity.
Aim 2 will determine the effect of the separate SHP-1 constructs on raft-associated signaling and assembly of rafts downstream of MHC II. Finally, Aim 3 will determine the effect of each construct on Ag presentation as determined by assaying activation of T cells stimulated by APCs expressing either protein. From our model, we predict that the raft-targeted SHP-1 will specifically inhibit MHC II-dependent signaling and capping of rafts, and this will coincide with a diminished ability of the APCs to stimulate T cells. Altogether, this research will instruct us regarding events leading to the onset of adaptive immune responses through presentation of Ag to T cells, and will suggest avenues that will allow us to augment or inhibit these responses.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR015577-09
Application #
7720049
Study Section
Special Emphasis Panel (ZRR1-RI-8 (01))
Project Start
2008-03-01
Project End
2009-02-28
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
9
Fiscal Year
2008
Total Cost
$72,786
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
077333797
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Hu, Zihua; Jiang, Kaiyu; Frank, Mark Barton et al. (2018) Modeling Transcriptional Rewiring in Neutrophils Through the Course of Treated Juvenile Idiopathic Arthritis. Sci Rep 8:7805
Hu, Zihua; Jiang, Kaiyu; Frank, Mark Barton et al. (2016) Complexity and Specificity of the Neutrophil Transcriptomes in Juvenile Idiopathic Arthritis. Sci Rep 6:27453
Molineros, Julio E; Maiti, Amit K; Sun, Celi et al. (2013) Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet 9:e1003222
Smith, Kenneth; Muther, Jennifer J; Duke, Angie L et al. (2013) Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis. Immunobiology 218:745-54
Dozmorov, Igor; Dominguez, Nicolas; Sestak, Andrea L et al. (2013) Evidence of dynamically dysregulated gene expression pathways in hyperresponsive B cells from African American lupus patients. PLoS One 8:e71397
Jiang, Kaiyu; Frank, Mark; Chen, Yanmin et al. (2013) Genomic characterization of remission in juvenile idiopathic arthritis. Arthritis Res Ther 15:R100
Kurien, Biji T; D'Sousa, Anil; Bruner, Benjamin F et al. (2013) Prolidase deficiency breaks tolerance to lupus-associated antigens. Int J Rheum Dis 16:674-80
Lessard, Christopher J; Adrianto, Indra; Ice, John A et al. (2012) Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet 90:648-60
Weckerle, Corinna E; Mangale, Dorothy; Franek, Beverly S et al. (2012) Large-scale analysis of tumor necrosis factor ? levels in systemic lupus erythematosus. Arthritis Rheum 64:2947-52
James, Judith A; Robertson, Julie M (2012) Lupus and Epstein-Barr. Curr Opin Rheumatol 24:383-8

Showing the most recent 10 out of 194 publications